Position in GALT
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$189,720
-$93,160 QoQ
Shares Held
68,000
0.0% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TRUIST FINANCIAL CORP holds $112,535,820 across 48 Biotechnology names. GALT ranks #40 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
114,449 | $51,106,055 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
40,108 | $30,989,044 | |
| 3 | ARGX |
Argenx SE
|
3,878 | $2,831,908 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,701 | $2,548,029 | |
| 5 | INSM |
INSMED Inc
|
15,416 | $2,520,822 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
10,207 | $1,929,631 | |
| 7 | EXEL |
Exelixis, Inc.
|
32,818 | $1,407,563 | |
| 8 | RPRX |
Royalty Pharma plc
|
29,108 | $1,396,310 |
All Filings in GALT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $189,720 | 68,000 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $282,880 | 68,000 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $288,320 | 68,000 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $143,480 | 68,000 | Shares | Defined | 2025-07-18 | |
| No filing history on record for this holder in this stock. | ||||||